Peginterferon alfa-2b and ribavirin in chronic hepatitis C relapse: new indication. For some patients.
When patients with chronic hepatitis C relapse after initial treatment with interferon alfa plus ribavirin, the peginterferon alfa and ribavirin combination can be beneficial.
D002986:Clinical Trials as Topic; D017277:Drug Approval; D004359:Drug Therapy, Combination; D005060:Europe; D016174:Hepacivirus / Q000187:drug effects; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D055502:Secondary Prevention; D019562:Viral Load
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin